Research progress on the application of eosinophils in the diagnosis and treatment of COVID-19

Zhou X., Zhao Q., Cai M., Mao J., Zhong Y., Liu X., Liu K., Yang J., Lei X., Rao R., Liu L., Tan H.

Abstract


Abstract
This review summarizes recent research progress on the role of eosinophils in the diagnosis and treatment of COVID-19. Eosinophils, traditionally known for their involvement in allergic responses and parasitic infections, have emerged as important biomarkers in COVID-19 disease progression. Studies indicate that eosinophil counts correlate with disease severity, recovery stages, and immune response modulation. The dynamic changes in eosinophil levels may aid in early diagnosis, prognosis evaluation, and treatment monitoring. Additionally, therapeutic strategies targeting eosinophil-mediated pathways are being explored to mitigate inflammation and improve clinical outcomes. This review highlights current findings, challenges, and future perspectives on leveraging eosinophil-related mechanisms in managing COVID-19.


Full text:

PDF

References


Zhou X., Zhao Q., Cai M., Mao J., Zhong Y., Liu X., Liu K., Yang J., Lei X., Rao R., Liu L., Tan H.